J&J Prices $15B in Senior Notes
Ticker: JNJ · Form: 8-K · Filed: 2024-05-17T00:00:00.000Z
Sentiment: neutral
Topics: debt-issuance, financing, notes
Related Tickers: JNJ
TL;DR
J&J just dropped $15B in new debt across multiple maturities.
AI Summary
On May 17, 2024, Johnson & Johnson filed an 8-K report detailing the issuance of new debt. The company announced the pricing of $15 billion aggregate principal amount of senior unsecured notes. These notes are due in installments ranging from 2024 to 2054, with specific tranches including $1.5 billion due 2024, $2 billion due 2026, $3 billion due 2029, $3.5 billion due 2034, and $5 billion due 2054.
Why It Matters
Johnson & Johnson's issuance of $15 billion in notes indicates its ongoing financing activities and potential use of funds for operations, acquisitions, or debt refinancing.
Risk Assessment
Risk Level: low — This filing is a routine debt issuance announcement and does not contain negative news or significant changes in business operations.
Key Numbers
- $15.0B — Senior Notes Issued (Total principal amount of debt raised by Johnson & Johnson.)
- $1.5B — Notes Due 2024 (Portion of the new debt maturing in the current year.)
- $5.0B — Notes Due 2054 (Longest maturity tranche of the new debt issuance.)
Key Players & Entities
- Johnson & Johnson (company) — Registrant
- $15 billion (dollar_amount) — Aggregate principal amount of senior unsecured notes
- 2024 (date) — Maturity year for a tranche of notes
- 2026 (date) — Maturity year for a tranche of notes
- 2029 (date) — Maturity year for a tranche of notes
- 2034 (date) — Maturity year for a tranche of notes
- 2054 (date) — Maturity year for a tranche of notes
FAQ
What is the total principal amount of the senior unsecured notes issued by Johnson & Johnson?
Johnson & Johnson priced $15 billion aggregate principal amount of senior unsecured notes.
What are the maturity dates for the different tranches of notes issued?
The notes are due in 2024, 2026, 2029, 2034, and 2054.
What is the amount of notes due in 2024?
There is $1.5 billion aggregate principal amount of notes due in 2024.
What is the amount of notes due in 2054?
There is $5 billion aggregate principal amount of notes due in 2054.
What is the purpose of this debt issuance?
The filing does not explicitly state the purpose of the debt issuance, but it is a common financing activity for large corporations.
From the Filing
0000200406-24-000053.txt : 20240517 0000200406-24-000053.hdr.sgml : 20240517 20240517112136 ACCESSION NUMBER: 0000200406-24-000053 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20240517 ITEM INFORMATION: Other Events FILED AS OF DATE: 20240517 DATE AS OF CHANGE: 20240517 FILER: COMPANY DATA: COMPANY CONFORMED NAME: JOHNSON & JOHNSON CENTRAL INDEX KEY: 0000200406 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 221024240 STATE OF INCORPORATION: NJ FISCAL YEAR END: 1229 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-03215 FILM NUMBER: 24958325 BUSINESS ADDRESS: STREET 1: ONE JOHNSON & JOHNSON PLZ CITY: NEW BRUNSWICK STATE: NJ ZIP: 08933 BUSINESS PHONE: 732-524-2455 MAIL ADDRESS: STREET 1: ONE JOHNSON & JOHNSON PLZ CITY: NEW BRUNSWICK STATE: NJ ZIP: 08933 8-K 1 jnj-20240517.htm 8-K jnj-20240517 0000200406 false 0000200406 2024-05-17 2024-05-17 0000200406 us-gaap:CommonStockMember 2024-05-17 2024-05-17 0000200406 jnj:A0.650NotesDue2024Member 2024-05-17 2024-05-17 0000200406 jnj:A5.50NotesDue2024Member 2024-05-17 2024-05-17 0000200406 jnj:A1.150NotesDue2028Member 2024-05-17 2024-05-17 0000200406 jnj:A1.650NotesDue2035Member 2024-05-17 2024-05-17 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934   Date of report (Date of earliest event reported):  May 17, 2024 Johnson & Johnson  (Exact name of registrant as specified in its charter)    New Jersey 1-3215 22-1024240 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.) One Johnson & Johnson Plaza , New Brunswick , New Jersey    08933   (Address of Principal Executive Offices) Registrant's telephone number, including area code ( 732) 524-0400   Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:   ☐             Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)  ☐            Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)  ☐            Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17                CFR 240.14d-2(b))  ☐            Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17                CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, Par Value $1.00 JNJ New York Stock Exchange 0.650% Notes Due May 2024 JNJ24C New York Stock Exchange 5.50% Notes Due November 2024 JNJ24BP New York Stock Exchange 1.150% Notes Due November 2028 JNJ28 New York Stock Exchange 1.650% Notes Due May 2035 JNJ35 New York Stock Exchange   Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).     Emerging growth company ☐   If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant